Balyasny Asset Management LLC Charles River Laboratories International, Inc. Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 5,700 shares of CRL stock, worth $953,496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,700Holding current value
$953,496% of portfolio
0.0%Shares
21 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$851 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$365 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$302 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$302 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.51B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...